Post by Zai Lab
28,937 followers
We're pleased to announce that the European Medicines Agency has granted Orphan Drug Designation to our potential first-in-class targeted antibody-drug conjugate for the treatment of pulmonary neuroendocrine carcinomas(pNECs). pNECs are aggressive cancers with limited available treatment options. Learn more about our work to address this significant patient need: https://lnkd.in/ed4qyVwU #SCLC #Innovation #Oncology #ADC
Video Content